Cargando…
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial
Regional variations exist in the epidemiology of peripheral artery disease (PAD), in comorbidities, use of secondary prevention, and outcomes. Large studies of these variations in worldwide populations are rare. The EUCLID (Examining Use of tiCagreLor In peripheral artery Disease) trial included 13,...
Autores principales: | Norgren, Lars, North, Rebecca, Baumgartner, Iris, Berger, Jeffrey S, Blomster, Juuso I, Hiatt, William R, Jones, W Schuyler, Katona, Brian G, Mahaffey, Kenneth W, Mulder, Hillary, Patel, Manesh R, Rockhold, Frank W, Fowkes, F Gerry R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808360/ https://www.ncbi.nlm.nih.gov/pubmed/34516308 http://dx.doi.org/10.1177/1358863X211038620 |
Ejemplares similares
-
Understanding Study Drug Discontinuation Through EUCLID
por: Weissler, E. Hope, et al.
Publicado: (2022) -
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
por: Galani, Jemi, et al.
Publicado: (2021) -
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID
por: Samsky, Marc D., et al.
Publicado: (2021) -
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial
por: Rymer, Jennifer A., et al.
Publicado: (2020) -
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease
por: Szarek, Michael, et al.
Publicado: (2022)